Related Experiment Videos

FDG uptake within regionally stunned myocardium

E O McFalls1, H Ward

  • 1Department of Cardiology, Veteran's Administration Medical Center, Minneapolis, MN 55417, USA.

American Journal of Cardiac Imaging
|October 1, 1995
PubMed

Insights

Myocardial stunning, a post-ischemic dysfunction, can be identified by positron emission tomography. This technique reveals a "flow-metabolism mismatch," predicting which patients benefit from reperfusion therapies.

Area of Science:

  • Cardiology
  • Nuclear Medicine
  • Medical Imaging

Background:

  • Myocardial function can be depressed without overt ischemia or infarction.
  • Myocardial stunning is defined as persistent contractile depression after ischemia and reperfusion.

Purpose of the Study:

  • To review the role of positron emission tomography in identifying myocardial viability.
  • To highlight the significance of the time course of fluorine 18-fluorodeoxyglucose uptake in stunned myocardium.

Main Methods:

  • Utilizing positron emission tomography to assess myocardial viability.
  • Evaluating fluorine 18-fluorodeoxyglucose (FDG) uptake in relation to perfusion.
  • Identifying the
  • flow-metabolism mismatch
  • pattern.

Main Results:

  • Enhanced FDG uptake relative to perfusion indicates viability in stunned myocardium.
  • The "flow-metabolism mismatch" pattern predicts response to reperfusion therapies.
  • The temporal dynamics of FDG uptake are crucial for understanding stunned myocardium.

Conclusions:

  • Positron emission tomography is vital for detecting myocardial viability in stunned regions.
  • Understanding the time course of FDG uptake enhances the clinical utility of imaging.
  • Identifying stunned myocardium aids in selecting patients for reperfusion therapies.

Related Concept Videos